These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 21474975)

  • 1. Erythropoietin: a hormone with multiple functions.
    Lombardero M; Kovacs K; Scheithauer BW
    Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
    Jelkmann W; Wagner K
    Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research advances in expression and functions of erythropoietin and erythropoietin receptor in cancers].
    Li M; Lu Y; Chen XQ
    Ai Zheng; 2008 Jun; 27(6):667-72. PubMed ID: 18570746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F; Lee A
    Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-hematogenic activity of erythropoietin].
    Stárka L; Dušková M
    Vnitr Lek; 2019; 65(7-8):515-519. PubMed ID: 31487995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The erythropoietin receptor in normal and cancer tissues.
    Jelkmann W; Bohlius J; Hallek M; Sytkowski AJ
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):39-61. PubMed ID: 18434185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of erythropoietin action.
    Koury MJ; Bondurant MC
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):20-3. PubMed ID: 1656733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin and the vascular wall: the controversy continues.
    Jelkmann W; Elliott S
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23 Suppl 1():S37-43. PubMed ID: 22682530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin and neuroprotection].
    Chatagner A; Hüppi PS; Ha-Vinh Leuchter R; Sizonenko S
    Arch Pediatr; 2010 Sep; 17 Suppl 3():S78-84. PubMed ID: 20728813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression.
    Hedley BD; Allan AL; Xenocostas A
    Clin Cancer Res; 2011 Oct; 17(20):6373-80. PubMed ID: 21750199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pleiotropic effects of erythropoietin].
    Kes P; Basić-Jukić N; Furić-Cunko V
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced murine hepatic tumors.
    Nakamatsu K; Nishimura Y; Suzuki M; Kanamori S; Maenishi O; Yasuda Y
    Int J Clin Oncol; 2004 Jun; 9(3):184-8. PubMed ID: 15221603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.
    Brines M
    Blood Purif; 2010; 29(2):86-92. PubMed ID: 20093809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of c-Kit and erythropoietin receptor in erythropoiesis.
    Munugalavadla V; Kapur R
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):63-75. PubMed ID: 15780908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
    De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
    Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel renoprotective actions of erythropoietin: new uses for an old hormone.
    Johnson DW; Forman C; Vesey DA
    Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin regulates tumour growth of human malignancies.
    Yasuda Y; Fujita Y; Matsuo T; Koinuma S; Hara S; Tazaki A; Onozaki M; Hashimoto M; Musha T; Ogawa K; Fujita H; Nakamura Y; Shiozaki H; Utsumi H
    Carcinogenesis; 2003 Jun; 24(6):1021-9. PubMed ID: 12807756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin and the heart: physiological effects and the therapeutic perspective.
    Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G
    Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.